- Title
- What Is the Oncologic Risk of Stem Cell Treatment for Heart Disease?
- Creators
- Konstantinos E Hatzistergos - From the Department of Pathology (T.A.I.), Interdisciplinary Stem Cell Institute (K.E.H., A.B., J.G., JMH), Sylvester Cancer Center (T.A.I., J.G.), Braman Family Breast Cancer Institute (T.A.I.), and Department of Medicine, Cardiovascular Division (J.M.H.), Leonard M. Miller School of Medicine, University of Miami, Miami, FloridaArnon Blum - From the Department of Pathology (T.A.I.), Interdisciplinary Stem Cell Institute (K.E.H., A.B., J.G., JMH), Sylvester Cancer Center (T.A.I., J.G.), Braman Family Breast Cancer Institute (T.A.I.), and Department of Medicine, Cardiovascular Division (J.M.H.), Leonard M. Miller School of Medicine, University of Miami, Miami, FloridaTan A Ince - From the Department of Pathology (T.A.I.), Interdisciplinary Stem Cell Institute (K.E.H., A.B., J.G., JMH), Sylvester Cancer Center (T.A.I., J.G.), Braman Family Breast Cancer Institute (T.A.I.), and Department of Medicine, Cardiovascular Division (J.M.H.), Leonard M. Miller School of Medicine, University of Miami, Miami, FloridaJames M Grichnik - From the Department of Pathology (T.A.I.), Interdisciplinary Stem Cell Institute (K.E.H., A.B., J.G., JMH), Sylvester Cancer Center (T.A.I., J.G.), Braman Family Breast Cancer Institute (T.A.I.), and Department of Medicine, Cardiovascular Division (J.M.H.), Leonard M. Miller School of Medicine, University of Miami, Miami, FloridaJoshua M Hare - From the Department of Pathology (T.A.I.), Interdisciplinary Stem Cell Institute (K.E.H., A.B., J.G., JMH), Sylvester Cancer Center (T.A.I., J.G.), Braman Family Breast Cancer Institute (T.A.I.), and Department of Medicine, Cardiovascular Division (J.M.H.), Leonard M. Miller School of Medicine, University of Miami, Miami, Florida
- Publication Details
- Circulation research, Vol.108(11), pp.1300-1303
- Academic Unit
- Leadership Department; Miller School of Medicine; Interdisciplinary Stem Cell Institute
- Language
- English
- Resource Type
- Journal article
- PMID
- 21617132
- PMCID
- PMC3390911
- Record Identifier
- 991031560754302976
Journal article
What Is the Oncologic Risk of Stem Cell Treatment for Heart Disease?
Circulation research, Vol.108(11), pp.1300-1303
2011-05-27
PMCID: PMC3390911
PMID: 21617132
Metrics
11 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Citation topics
- 1 Clinical & Life Sciences
- 1.102 Stem Cell Research
- 1.102.110 Mesenchymal Stem Cells
- Web Of Science research areas
- Cardiac & Cardiovascular Systems
- Hematology
- Peripheral Vascular Disease
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites